An Observational Study on Emergence from Anaesthesia in Adults Following Sugammadex Administration as a Neuromuscular Blockade Reversal Agent
Overview
- Phase
- Not Applicable
- Status
- Not Applicable
- Sponsor
- K S HEGDE MEDICAL ACADEMY
- Enrollment
- 52
- Locations
- 1
- Primary Endpoint
- To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using
Overview
Brief Summary
This study focuses on evaluating the effectiveness and timeline of patient awakening after general anaesthesia when sugammadex is used as a neuromuscular blockade reversal agent. Sugammadex, a modified gamma cyclodextrin, is specifically designed to reverse the effects of steroidal neuromuscular blocking agents, such as rocuronium and vecuronium. The research assesses parameters such as time to return of spontaneous respiration, eye opening, ability to follow verbal commands, and extubation readiness. It also compares the recovery profile of sugammadex with traditional reversal agents like neostigmine, aiming to determine its safety, efficacy, and potential benefits in improving post-anaesthesia recovery.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients aged 18-60 years ASA-PS I and II Expected surgical duration less than 3 hours Patients undergoing elective surgeries.
Exclusion Criteria
- •1.Patient who cannot comprehend, uncooperative patient 2.Neuropsychiatric disease 3.Chronic alcohol or drug addict 4.Planned postoperative ICU Admission.
Outcomes
Primary Outcomes
To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using
Time Frame: To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using | 1.AVPU scale | 2.six screener test | 3.MiniCog test
1.AVPU scale
Time Frame: To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using | 1.AVPU scale | 2.six screener test | 3.MiniCog test
2.six screener test
Time Frame: To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using | 1.AVPU scale | 2.six screener test | 3.MiniCog test
3.MiniCog test
Time Frame: To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using | 1.AVPU scale | 2.six screener test | 3.MiniCog test
Secondary Outcomes
No secondary outcomes reported
Investigators
DR M Venkat karli
K S Hegde Medical Academy